ÂÜÀòÂÒÂ×

Aline LACROIX is currently engaged in a Research and Development Internship at PEP-Therapy since March 2023, focusing on the mechanism of action of PEP-010 and identifying new biomarkers associated with it. Previous experience includes an internship at Merck from June to September 2022, where Aline worked on identifying and addressing issues to secure a GMP End-to-End production of 2000L, and a brief operational internship at Sanofi Pasteur in June 2021. Aline holds a Master's degree from Alma Mater Studiorum – Università di Bologna and a Diplôme d'ingénieur in Biotechnology from ENSTBB Bordeaux INP. Additionally, Aline completed a Bachelor's degree in Life Sciences with a focus on Biochemistry, Cellular Biology, and Physiology at Université de Franche-Comté and pursued preparatory classes for grandes écoles at Lycée Victor Hugo, as well as a Baccalauréat Scientifique at Lycée Jean Michel.